AstraZeneca sues Innopharma for patent infringement

22-02-2016

AstraZeneca sues Innopharma for patent infringement

wavebreakmedia / Shutterstock.com

AstraZeneca has sued Innopharma over its attempt to market a generic version of breast cancer treatment drug Faslodex (fulvestrant).


AstraZeneca; Innopharma; breast cancer; ANDA; generic;

LSIPR